DSM Venturing cornerstones €10m funding round as Oxford-based Phynova progresses its blood-glucose Reducose® technology to commercial success. DSM Venturing, part of Royal DSM, a global leader in nutrition, health, and sustainable living, is the cornerstone investor in Oxford-based Phynova’s €10m funding round. Phynova is working towards fulfilling significant commercial orders for its Reducose® technology inRead more
Call: | +44 (0)1993 880 700 |
Skype: | Phynova Group Ltd |
Email: | [email protected] |